Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

797 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins.
Wang C, Kaufmann A, Kampschulte N, Elbelt U, Kassner U, Steinhagen-Thiessen E, Pietzner A, Schmöcker C, Datta D, Sanpietro T, Schebb NH, Weylandt KH, Rohwer N. Wang C, et al. Among authors: datta d. Atheroscler Plus. 2024 Feb 12;55:55-62. doi: 10.1016/j.athplu.2024.01.005. eCollection 2024 Mar. Atheroscler Plus. 2024. PMID: 38390468 Free PMC article.
HEART UK consensus statement on Lipoprotein(a): A call to action.
Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee. Cegla J, et al. Among authors: datta d. Atherosclerosis. 2019 Dec;291:62-70. doi: 10.1016/j.atherosclerosis.2019.10.011. Epub 2019 Oct 14. Atherosclerosis. 2019. PMID: 31704552 Free article. Review.
Corrigendum to "Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017" [Atherosclerosis 290 (November 2019) 44-51].
Pottle A, Thompson G, Barbir M, Bayly G, Cegla J, Cramb R, Dawson T, Eatough R, Kale V, Neuwirth C, Nicholson K, Payne J, Scott J, Soran H, Walji S, Watkins S, Weedon H, Datta DBN. Pottle A, et al. Atherosclerosis. 2020 Feb;294:16. doi: 10.1016/j.atherosclerosis.2019.12.015. Epub 2020 Jan 11. Atherosclerosis. 2020. PMID: 31935635 No abstract available.
Corrigendum to "HEART UK consensus statement on Lipoprotein(a): A call to action" [Atherosclerosis 291 (2019) 62-70].
Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee. Cegla J, et al. Among authors: datta d. Atherosclerosis. 2020 Mar;296:48. doi: 10.1016/j.atherosclerosis.2020.01.019. Epub 2020 Feb 1. Atherosclerosis. 2020. PMID: 32018073 No abstract available.
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK.
Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, Rees A, Khatib R, Cegla J, Byrne C, Qureshi N, Capps N, Ferns G, Payne J, Schofield J, Nicholson K, Datta D, Pottle A, Halcox J, Krentz A, Durrington P, Soran H; Heart UK's Medical Scientific and Research Committee. Iqbal Z, et al. Among authors: datta d. Atherosclerosis. 2020 Nov;313:126-136. doi: 10.1016/j.atherosclerosis.2020.09.008. Epub 2020 Sep 15. Atherosclerosis. 2020. PMID: 33045618 Free PMC article. Review.
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS).
Bashir B, Kwok S, Wierzbicki AS, Jones A, Dawson C, Downie P, Jenkinson F, Delaney H, Mansfield M, Datta D, Teoh Y, Hamilton P, Forrester N, O'Sullivan D, Ferdousi M, Durrington PN, AbdelRazik A, Gallo A, Moulin P, Soran H. Bashir B, et al. Among authors: datta d. Atherosclerosis. 2024 Apr;391:117476. doi: 10.1016/j.atherosclerosis.2024.117476. Epub 2024 Feb 10. Atherosclerosis. 2024. PMID: 38447437
HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.
France M, Rees A, Datta D, Thompson G, Capps N, Ferns G, Ramaswami U, Seed M, Neely D, Cramb R, Shoulders C, Barbir M, Pottle A, Eatough R, Martin S, Bayly G, Simpson B, Halcox J, Edwards R, Main L, Payne J, Soran H; for HEART UK Medical Scientific and Research Committee. France M, et al. Among authors: datta d. Atherosclerosis. 2016 Dec;255:128-139. doi: 10.1016/j.atherosclerosis.2016.10.017. Epub 2016 Nov 5. Atherosclerosis. 2016. PMID: 27839699 Free article. Review.
The future of clinical lipidology in the UK.
Cegla J, Datta D, Rees A, Soran H, Thompson G. Cegla J, et al. Among authors: datta d. Clin Med (Lond). 2024 Mar;24(2):100026. doi: 10.1016/j.clinme.2024.100026. Epub 2024 Feb 16. Clin Med (Lond). 2024. PMID: 38369129 Free PMC article. No abstract available.
797 results